Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatitis B | 6 | 2022 | 705 | 1.690 |
Why?
|
Hepatitis B virus | 7 | 2022 | 528 | 1.630 |
Why?
|
Mucormycosis | 4 | 2023 | 103 | 1.590 |
Why?
|
Aspergillosis | 2 | 2023 | 242 | 1.330 |
Why?
|
Virus Activation | 7 | 2022 | 322 | 1.110 |
Why?
|
Cytomegalovirus Infections | 7 | 2023 | 831 | 1.030 |
Why?
|
Agammaglobulinemia | 2 | 2023 | 171 | 0.980 |
Why?
|
Antibodies, Bispecific | 2 | 2024 | 196 | 0.960 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2022 | 5671 | 0.850 |
Why?
|
Mycoses | 5 | 2013 | 386 | 0.850 |
Why?
|
Antiviral Agents | 10 | 2022 | 3060 | 0.820 |
Why?
|
Respiratory Tract Infections | 2 | 2023 | 1010 | 0.740 |
Why?
|
Triazoles | 4 | 2019 | 903 | 0.700 |
Why?
|
Opportunistic Infections | 3 | 2015 | 376 | 0.690 |
Why?
|
Antifungal Agents | 9 | 2023 | 752 | 0.680 |
Why?
|
Hematologic Neoplasms | 6 | 2023 | 1896 | 0.670 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2012 | 611 | 0.550 |
Why?
|
Leukemia | 3 | 2010 | 1522 | 0.530 |
Why?
|
Immunocompromised Host | 9 | 2023 | 856 | 0.490 |
Why?
|
Transplantation | 2 | 2013 | 219 | 0.460 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1032 | 0.450 |
Why?
|
Hepatitis C | 2 | 2020 | 1584 | 0.410 |
Why?
|
Neutropenia | 3 | 2023 | 885 | 0.410 |
Why?
|
Multiple Myeloma | 4 | 2024 | 5146 | 0.400 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6075 | 0.400 |
Why?
|
Antibiotic Prophylaxis | 2 | 2008 | 636 | 0.400 |
Why?
|
Cytomegalovirus | 5 | 2021 | 756 | 0.400 |
Why?
|
Mycology | 1 | 2011 | 13 | 0.380 |
Why?
|
Mucorales | 1 | 2011 | 35 | 0.370 |
Why?
|
Pyrazoles | 2 | 2018 | 2009 | 0.360 |
Why?
|
Pyrimidines | 2 | 2018 | 3028 | 0.320 |
Why?
|
Viruses | 1 | 2012 | 375 | 0.310 |
Why?
|
Skin Diseases, Infectious | 1 | 2008 | 76 | 0.300 |
Why?
|
Soft Tissue Infections | 1 | 2008 | 168 | 0.270 |
Why?
|
Virus Diseases | 1 | 2012 | 718 | 0.260 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2018 | 242 | 0.250 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 746 | 0.250 |
Why?
|
B-Cell Maturation Antigen | 2 | 2023 | 149 | 0.250 |
Why?
|
Cord Blood Stem Cell Transplantation | 3 | 2018 | 305 | 0.250 |
Why?
|
Hepatitis B Surface Antigens | 3 | 2022 | 294 | 0.250 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2007 | 238 | 0.240 |
Why?
|
Bacterial Infections | 1 | 2013 | 1390 | 0.240 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2007 | 343 | 0.230 |
Why?
|
Hepatitis B Antibodies | 2 | 2022 | 155 | 0.220 |
Why?
|
Lung Transplantation | 1 | 2012 | 1310 | 0.210 |
Why?
|
Echinocandins | 1 | 2023 | 53 | 0.210 |
Why?
|
Physicians | 1 | 2021 | 4591 | 0.210 |
Why?
|
Drainage | 1 | 2008 | 1157 | 0.210 |
Why?
|
Neoplasms | 4 | 2022 | 22170 | 0.200 |
Why?
|
Anti-Infective Agents | 2 | 2012 | 983 | 0.200 |
Why?
|
Polyomavirus Infections | 2 | 2014 | 194 | 0.200 |
Why?
|
Nitriles | 2 | 2019 | 971 | 0.190 |
Why?
|
Tumor Virus Infections | 2 | 2014 | 438 | 0.190 |
Why?
|
Hepacivirus | 2 | 2019 | 1336 | 0.180 |
Why?
|
Humans | 54 | 2024 | 761504 | 0.180 |
Why?
|
Fungi | 1 | 2023 | 338 | 0.180 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3156 | 0.170 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 1408 | 0.170 |
Why?
|
Transplantation Conditioning | 2 | 2018 | 1590 | 0.160 |
Why?
|
Tacrolimus | 1 | 2022 | 733 | 0.160 |
Why?
|
Pneumocystis carinii | 2 | 2018 | 72 | 0.160 |
Why?
|
DNA, Viral | 3 | 2022 | 2202 | 0.160 |
Why?
|
Postoperative Complications | 3 | 2020 | 15631 | 0.150 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.150 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13639 | 0.140 |
Why?
|
Adult | 25 | 2023 | 221177 | 0.140 |
Why?
|
BK Virus | 2 | 2014 | 123 | 0.140 |
Why?
|
Adenine | 3 | 2018 | 987 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1469 | 0.140 |
Why?
|
Latent Tuberculosis | 1 | 2019 | 224 | 0.140 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2018 | 1073 | 0.130 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 410 | 0.130 |
Why?
|
Middle Aged | 25 | 2023 | 220895 | 0.130 |
Why?
|
Chemoprevention | 1 | 2017 | 326 | 0.120 |
Why?
|
Transplantation, Homologous | 6 | 2018 | 4806 | 0.120 |
Why?
|
Pyridines | 2 | 2019 | 2875 | 0.120 |
Why?
|
Aged, 80 and over | 8 | 2019 | 58976 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2022 | 1374 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2023 | 80636 | 0.120 |
Why?
|
Rhizomucor | 1 | 2014 | 3 | 0.120 |
Why?
|
Aged | 18 | 2023 | 169289 | 0.120 |
Why?
|
Male | 26 | 2023 | 360804 | 0.120 |
Why?
|
Fetal Blood | 2 | 2018 | 1347 | 0.110 |
Why?
|
Acute Disease | 3 | 2010 | 7237 | 0.110 |
Why?
|
Immunosuppressive Agents | 3 | 2020 | 4174 | 0.110 |
Why?
|
Methotrexate | 1 | 2020 | 1719 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2115 | 0.100 |
Why?
|
Piperidines | 2 | 2018 | 1656 | 0.100 |
Why?
|
Tissue Transplantation | 1 | 2012 | 128 | 0.100 |
Why?
|
Virology | 1 | 2012 | 75 | 0.100 |
Why?
|
Mannans | 1 | 2011 | 58 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.100 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2011 | 57 | 0.090 |
Why?
|
Amphotericin B | 1 | 2011 | 142 | 0.090 |
Why?
|
beta-Glucans | 1 | 2011 | 123 | 0.090 |
Why?
|
HIV | 1 | 2018 | 1582 | 0.090 |
Why?
|
Lymphadenitis | 1 | 2011 | 99 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2017 | 558 | 0.090 |
Why?
|
Female | 22 | 2023 | 392644 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5315 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1157 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1372 | 0.090 |
Why?
|
DNA, Ribosomal | 1 | 2011 | 300 | 0.090 |
Why?
|
DNA, Fungal | 1 | 2011 | 275 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.080 |
Why?
|
Young Adult | 8 | 2019 | 59243 | 0.080 |
Why?
|
Candidiasis | 1 | 2011 | 365 | 0.080 |
Why?
|
Candida albicans | 1 | 2011 | 372 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 1914 | 0.080 |
Why?
|
Cross Infection | 1 | 2017 | 1422 | 0.080 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2693 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39106 | 0.070 |
Why?
|
DNA Primers | 1 | 2011 | 2819 | 0.070 |
Why?
|
HIV Reverse Transcriptase | 1 | 2007 | 212 | 0.070 |
Why?
|
Face | 1 | 2012 | 1026 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14666 | 0.070 |
Why?
|
Cohort Studies | 4 | 2019 | 41487 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11742 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2019 | 64680 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1533 | 0.060 |
Why?
|
Graft Rejection | 2 | 2020 | 4445 | 0.060 |
Why?
|
Community-Acquired Infections | 1 | 2008 | 469 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13380 | 0.060 |
Why?
|
Incidence | 4 | 2022 | 21353 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1265 | 0.060 |
Why?
|
Risk Factors | 7 | 2022 | 74206 | 0.060 |
Why?
|
Graft vs Host Disease | 3 | 2014 | 3029 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5440 | 0.060 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 415 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1527 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 10209 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2017 | 3613 | 0.050 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2007 | 587 | 0.050 |
Why?
|
Patient Selection | 2 | 2021 | 4244 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 329 | 0.050 |
Why?
|
Time Factors | 3 | 2012 | 39967 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12463 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2008 | 1048 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.040 |
Why?
|
Hepatitis B Core Antigens | 1 | 2020 | 90 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2022 | 412 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1787 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4740 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2020 | 12341 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4544 | 0.040 |
Why?
|
Acetates | 1 | 2021 | 321 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2022 | 424 | 0.040 |
Why?
|
Stem Cell Transplantation | 2 | 2020 | 1600 | 0.040 |
Why?
|
Tuberculin Test | 1 | 2019 | 206 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1835 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2491 | 0.040 |
Why?
|
Rubella | 1 | 2018 | 55 | 0.040 |
Why?
|
Herpes Zoster Vaccine | 1 | 2018 | 49 | 0.040 |
Why?
|
Mumps | 1 | 2018 | 71 | 0.040 |
Why?
|
HIV Infections | 2 | 2018 | 17351 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8529 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6374 | 0.030 |
Why?
|
Societies, Medical | 2 | 2020 | 3905 | 0.030 |
Why?
|
Measles | 1 | 2018 | 183 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1667 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2048 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7390 | 0.030 |
Why?
|
Quinazolines | 1 | 2021 | 1371 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15500 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1422 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1475 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3123 | 0.030 |
Why?
|
Anthracyclines | 1 | 2015 | 284 | 0.030 |
Why?
|
Myeloablative Agonists | 1 | 2014 | 209 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 603 | 0.030 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 686 | 0.030 |
Why?
|
Drug Dosage Calculations | 1 | 2012 | 117 | 0.020 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 348 | 0.020 |
Why?
|
Prospective Studies | 3 | 2024 | 54425 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 2019 | 1375 | 0.020 |
Why?
|
Fluconazole | 1 | 2011 | 157 | 0.020 |
Why?
|
Galactose | 1 | 2011 | 297 | 0.020 |
Why?
|
Adolescent | 3 | 2017 | 88319 | 0.020 |
Why?
|
Serum | 1 | 2011 | 209 | 0.020 |
Why?
|
Diarrhea | 1 | 2017 | 1318 | 0.020 |
Why?
|
HIV-1 | 1 | 2007 | 6863 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4021 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 273 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2521 | 0.020 |
Why?
|
Proteoglycans | 1 | 2011 | 803 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8830 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3600 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1551 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21012 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2218 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1755 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2007 | 36 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3201 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1394 | 0.020 |
Why?
|
Didanosine | 1 | 2007 | 151 | 0.020 |
Why?
|
Dideoxynucleosides | 1 | 2007 | 135 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3514 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1880 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5428 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 867 | 0.020 |
Why?
|
Lamivudine | 1 | 2007 | 366 | 0.020 |
Why?
|
Tissue Donors | 1 | 2015 | 2331 | 0.020 |
Why?
|
Codon | 1 | 2007 | 601 | 0.020 |
Why?
|
Viral Load | 1 | 2014 | 3332 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29625 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2015 | 2827 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 621 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12725 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3688 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4811 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2007 | 877 | 0.010 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 862 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1595 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8465 | 0.010 |
Why?
|
Graft Survival | 1 | 2012 | 3819 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6310 | 0.010 |
Why?
|
HeLa Cells | 1 | 2007 | 3093 | 0.010 |
Why?
|
Pneumonia | 1 | 2012 | 2143 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
Skin | 1 | 2014 | 4484 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7529 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9318 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15842 | 0.010 |
Why?
|
Lung | 1 | 2014 | 10000 | 0.010 |
Why?
|
United States | 1 | 2015 | 72334 | 0.000 |
Why?
|
Brain | 1 | 2014 | 27112 | 0.000 |
Why?
|